9781405112925

Fatty Liver Disease : NASH and Related Disorders

by ; ; ;
  • ISBN13:

    9781405112925

  • ISBN10:

    1405112921

  • Format: Hardcover
  • Copyright: 2004-12-10
  • Publisher: Wiley-Blackwell
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $252.95 Save up to $10.12
  • Buy New
    $242.83
    Add to Cart Free Shipping

    PRINT ON DEMAND: 2-4 WEEKS. THIS ITEM CANNOT BE CANCELLED OR RETURNED.

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

Summary

Fatty Liver Diseases: NASH and Related Disorders is an unusual book: it combines a practical approach for students and physicians concerned with the problem with a clear overview on the causative mechanisms. It appeals to doctors and other health care workers who encounter this problem, as well as to pathologists and investigators interested in the field of liver disease. It will improve your diagnostic acumen for people with abnormal liver tests, advance your knowledge about this important subject and help with your specialist or undergraduate exams, and management of a common disorder.

Table of Contents

Contributors vii
Preface x
Overview: an introduction to Nash and related fatty liver disorders
1(12)
Geoffrey C. Farrell
Jacob George
Pauline de la M. Hall
Arthur J. McCullough
Pathology of hepatic steatosis, Nash and related conditions
13(10)
Pauline de la M. Hall
Richard Kirsch
The epidemiology and risk factors of Nash
23(15)
Arthur J. McCullough
Insulin resistance in NAFLD: potential mechanisms and therapies
38(17)
Varman T. Samuel
Gerald I. Shulman
Nash as part of the metabolic (insulin resistance) syndrome
55(11)
Giulio Marchesini
Elisabetta Bugianesi
Nash is a genetically determined disease
66(10)
Christopher P. Day
Ann K. Daly
The pathogenesis of Nash: human studies
76(15)
Arun J. Sanyal
Animal models of steatohepatitis
91(18)
Geoffrey C. Farrell
Fatty acid metabolism and lipotoxicity in the pathogenesis of NAFLD/Nash
109(14)
Nathan M. Bass
Raphael B. Merriman
Cytokines and inflammatory recruitment in Nash: experimental and human studies
123(9)
Zhiping Li
Anna-Mae Diehl
Mitochondrial injury and Nash
132(11)
Bernard Fromenty
Dominique Pessayre
Cell biology of Nash: fibrosis and cell proliferation
143(16)
Isabelle A. Leclercq
Yves Horsmans
Clinical manifestations and diagnosis of NAFLD
159(9)
Stephen A. Harrison
Brent Neuschwander-Tetri
The clinical outcome of NAFLD including cryptogenic cirrhosis
168(13)
Stephen H. Caldwell
Anita Impagliazzo Hylton
Practical approach to the diagnosis and management of people with fatty liver diseases
181(13)
Jacob George
Geoffrey C. Farrell
Management of Nash: current and future perspectives on treatment
194(14)
Paul Angulo
Keith D. Lindor
NAFLD, Nash and orthotopic liver transplantation
208(10)
Anne Burke
Michael R. Lucey
NAFLD/Nash is not just a `Western' problem: some perspectives on NAFLD/Nash from the East
218(11)
Shivakumar Chitturi
Jacob George
NAFLD/Nash in children
229(12)
Joel E. Lavine
Jeffrey B. Schwimmer
Steatohepatitis resulting from intestinal bypass
241(8)
Christiane Bode
J. Christian Bode
Specific disorders associated with NAFLD
249(14)
Geraldine M. Grant
Vikas Chandhoke
Zobair M. Younossi
Hepatocellular carcinoma in NAFLD
263(13)
Vlad Ratziu
Thierry Poynard
Does Nash or NAFLD contribute to comorbidity of other liver diseases?
276(13)
Andrew D. Clouston
Elizabeth E. Powell
Recent advances
289(14)
Richard Kirsch
Pauline de la M. Hall
Jacob George
Arthur J. McCullough
Geoffrey C. Farrell
Index 303

Rewards Program

Write a Review